Skip to main content

John William Sleasman

Dr. Glenn A. Kiser and Eltha Muriel Kiser Professor of Pediatrics
Pediatrics, Allergy and Immunology
203 Research Dr, MSRB 1, Durham, NC 27710

Selected Grants


Congenital Athymia Patient Registry

Clinical TrialPrincipal Investigator · Awarded by Enzyvant · 2022 - 2027

Duke Program of Training in Pulmonary ReSearch to Promote, Engage and Retain Academic Researchers (PROSPER)

Inst. Training Prgm or CMEPreceptor · Awarded by National Institutes of Health · 2022 - 2026

Duke Center for Advancement of Child Health (CAtCH).

Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2021 - 2026

Interdisciplinary Research Training Program in AIDS

Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2010 - 2025

Vaccine-induced SARS-CoV-2-specific T cell responses in patients with X-linked Agammaglobulinemia

ResearchPrincipal Investigator · Awarded by University of North Carolina - Chapel Hill · 2023 - 2024

Congenital Athymia Patient Registry

Clinical TrialPrincipal Investigator · Awarded by Enzyvant · 2022 - 2027

Duke Program of Training in Pulmonary ReSearch to Promote, Engage and Retain Academic Researchers (PROSPER)

Inst. Training Prgm or CMEPreceptor · Awarded by National Institutes of Health · 2022 - 2026

Duke Center for Advancement of Child Health (CAtCH).

Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2021 - 2026

Interdisciplinary Research Training Program in AIDS

Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2010 - 2025

Vaccine-induced SARS-CoV-2-specific T cell responses in patients with X-linked Agammaglobulinemia

ResearchPrincipal Investigator · Awarded by University of North Carolina - Chapel Hill · 2023 - 2024

LOC-IMPAACT Leadership Group

ResearchPrincipal Investigator · Awarded by Johns Hopkins University · 2020 - 2024

Research Training in Allergy and Clinical Immunology

Inst. Training Prgm or CMEPrincipal Investigator · Awarded by University of North Carolina - Chapel Hill · 2000 - 2024

Duke Resident Physician-Scientist Program - NIAID

Inst. Training Prgm or CMEPreceptor · Awarded by National Institutes of Health · 2018 - 2023

Consequences of marijuana use on inflammatory pathways in HIV-infected youth

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2017 - 2023

Impact of maternal HIV infection on immune priming of their uninfected infants

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2020 - 2023

Jeffrey Modell Diagnostic and Research Center for Primary Immunodeficiences

Public ServicePrincipal Investigator · Awarded by Jeffrey Modell Foundation · 2016 - 2022

Consequences of marijuana use on inflammatory pathways impacting neurocognitive function in Youth with HIV (YWH)

ResearchCollaborator · Awarded by University of North Carolina - Chapel Hill · 2021 - 2022

LOC-IMPAACT Leadership Group

ResearchPrincipal Investigator · Awarded by Johns Hopkins University · 2014 - 2020

Effect of breast feeding on immunologic priming in young infants

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2012 - 2018

Office of AIDS Research Strategic Initiative to Develop and Overarching Research Agenda for Children and Youth

ResearchPrincipal Investigator · Awarded by Johns Hopkins University · 2017 - 2017

ATN Coordinating Center

ResearchPrincipal Investigator · Awarded by University of Alabama at Birmingham · 2014 - 2017

Substance Use and Immunity in HIV+ Adolescents by Systems Biology

ResearchPrincipal Investigator · Awarded by University of Florida · 2014 - 2016

Asthma Clinical Research Center of the American Lung Association

ResearchCo Investigator · Awarded by American Lung Association · 2009 - 2016

Substance Abuse and Immunity in HIV+ Adolescents by Systems Biology

ResearchPrincipal Investigator · Awarded by University of Florida · 2014 - 2015

ATN Coordinating Center

ResearchPrincipal Investigator · Awarded by University of Alabama · 2013 - 2014

External Relationships


  • Chinook Therapeutics
  • Sumitomo Pharma America, Inc.

This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.